| 标题 |
Abstract P3-11-01: Neoadjuvant chemotherapy with or without bevacizumab or everolimus: Survival analysis of The HER2-negative cohort of the GEPARQUINTO study (GBG 44) |
| 网址 | |
| DOI |
10.1158/1538-7445.sabcs14-p3-11-01
doi
|
| 其它 |
期刊:Cancer Research 作者:Bernd Gerber; Sibylle Loibl; Michael Untch; Holger Eidtmann; Mahdi Rezai; et al 出版日期:2015-05-05 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)